20,000 Covid-19 vaccine doses donated to Lesotho

RNS Number : 4990A
Gem Diamonds Limited
02 June 2021
 

2 June 2021

GEM DIAMONDS LIMITED

("Gem Diamonds" or "the Company")

 

Donation of 20,000 Covid-19 vaccine doses to Lesotho

 

Gem Diamonds is pleased to announce that its subsidiary, Letšeng Diamonds, in Lesotho has acquired 20,000 doses of the Johnson & Johnson Covid-19 vaccine. The doses have been donated to the Government of Lesotho, and will be distributed according to the guidelines set out in the Government's vaccine roll out plan, as part of the Company's ongoing commitment to the Covid-19 pandemic response and infection prevention.

 

Gem Diamonds is proud of its longstanding partnership with the Government of Lesotho and has made a significant contribution to the national effort to control the spread of the virus, engaging extensively with the Ministry of Health.

 

In addition to the provision of these vaccine doses, Gem Diamonds has donated a modular unit for use as a testing laboratory and some 17 oxygen concentrator machines to ten hospitals and clinics throughout Lesotho. In the project communities, it has worked to raise community awareness and implemented measures such as the distribution of food parcels, seeds for sustainable vegetable crops and personal protective equipment, including masks, hand washing taps and hand sanitisers among local communities. 

 

Further information on the Group's effort to tackle Covid-19 as well as its Covid-19 scanning, testing and preventative measures and Sustainability policies can be found in the 2020 Sustainable Development Report:

https://www.gemdiamonds-reports.co.za/reports/sd-2021/pdf/gem-diamonds-sus-report-2020.pdf

 

The Prime Minister of Lesotho, Dr Moeketsi Majoro said:

 

"I would like to thank Letšeng Diamonds on behalf of the Basotho Nation for the generous financial contribution that they have made which shall be used for the purchase of 20,000 doses of the Johnson & Johnson Covid-19 vaccine."

 

 

Gem Diamonds' CEO, Clifford Elphick, commented:

 

" Since the onset of the Covid-19 pandemic, we have been wholly committed to supporting Lesotho at a local and national level, as well as to protecting all of our employees and contractors. The donation of 20,000 Covid-19 vaccine doses to the people of Lesotho is another significant step in ensuring that Gem Diamonds continues to make a positive impact on the lives of the surrounding communities."

 

 

For further information:

 

Gem Diamonds

Susan Wallace, Company Secretarial department

ir@gemdiamonds.com

 

 

Celicourt Communications

Mark Antelme / Oliver Mills

Tel:  +44 (0)  208 434 2643

 

The Gem Diamonds Limited LEI number is 213800RC2PGGMZQG8L67

About Gem Diamonds:

Gem Diamonds is a leading global diamond producer of high value diamonds. The Company owns 70% of the Letšeng mine in Lesotho. The Letšeng mine is famous for the production of large, top colour, exceptional white diamonds, making it the highest dollar per carat kimberlite diamond mine in the world.   www.gemdiamonds.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPUBWQUPGGRG
UK 100